GUFICBIO · Gufic Biosciences Limited · Financials
Market Cap
47.44B INR
Shares
100.28M
Volume · Nov 13
219.5K
Avg daily vol (3M)
124.82K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
9.44B
+15.2%
FY2026
Net Income
0
FY2026
Operating Cash Flow
449.68M
-63.3%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 |
|---|---|---|---|---|
| INR | 9.81B | 9.44B | 8.2B | 8.07B |
| INR | 308.2M | 308.33M | 210.65M | 170.17M |
| INR | 366.96M | 366.11M | 231.12M | 153.6M |
| INR | 993.14M | 865.49M | 941.43M | 1.16B |
| INR | 258.59M | 223.36M | 244.95M | 295.36M |
| INR | 223.13M | 0 | 0 | 861.36M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2024–FY2026: 29.75M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.